Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis

被引：78
|
作者：
Greco, A
Minghetti, L
Sette, G
Fieschi, C
Levi, G
机构：
[1] Ist Super Sanita, Lab Pathophysiol, I-00161 Rome, Italy
[2] Univ Rome La Sapienza, Dept Neurol Sci, I-00185 Rome, Italy
来源：
NEUROLOGY | 1999年 / 53卷 / 08期
关键词：
8-epi-prostaglandin F-2 alpha; prostaglandin E-2; CSF; MS; human; lipid peroxidation; oxidative stress;
D O I：
10.1212/WNL.53.8.1876
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The CSF level of the isoprostane 8-epi-prostaglandin (PG)-F-2 alpha (a reliable marker of oxidative stress in vivo) was three times higher in subjects with definite MS than in a benchmark group of subjects with other neurologic diseases. This increase was not correlated with that of PGE, levels, measured as an index of cyclooxygenase activity, and was much lower in steroid-treated patients. The levels of 8-epi-PGF(2 alpha) were moderately correlated with the degree of disability.
引用
收藏
页码：1876 / 1879
页数：4
相关论文
共 50 条
  • [41] Adiponectin Alleviates Cell Injury due to Cerebrospinal Fluid from Multiple Sclerosis Patients by Inhibiting Oxidative Stress and Proinflammatory Response
    Mallardo, Marta
    Signoriello, Elisabetta
    Lus, Giacomo
    Daniele, Aurora
    Nigro, Ersilia
    BIOMEDICINES, 2023, 11 (06)
  • [42] Oxidative Stress Imbalance in Multiple Sclerosis Patients
    Gironi, Maira
    Vaghi, Matilde
    Mariani, Enrica
    Cursano, Cristina
    di Stolfo, Valentina
    Tortorella, Paola
    Nemni, Raffaello
    Saresella, Marina
    Rovaris, Marco
    NEUROLOGY, 2012, 78
  • [43] Multiple Cerebrospinal Fluid Bands: Multiple Sclerosis?
    Chen, Yu
    Watts, Gail
    CLINICAL CHEMISTRY, 2011, 57 (07) : 1085 - 1086
  • [44] EVALUATION OF MULTIPLE-SCLEROSIS PATIENTS BY CEREBROSPINAL-FLUID
    KALEEMULLAH, AJ
    OKELL, RT
    MISSOURI MEDICINE, 1976, 73 (09) : 520 - 522
  • [45] Is Chlamydia pneumoniae present in cerebrospinal fluid of multiple sclerosis patients?
    Tondella, MLC
    Galagoda, G
    Gaydos, CA
    Boman, J
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (05) : 977 - 978
  • [46] Cerebrospinal fluid measures of disease activity in patients with multiple sclerosis
    Sellebjerg, F
    Christiansen, M
    Nielsen, PM
    Frederiksen, JL
    MULTIPLE SCLEROSIS, 1998, 4 (06): : 475 - 479
  • [47] Inflammatory and degenerative markers in cerebrospinal fluid of patients with multiple sclerosis
    Sladkova, V.
    Mares, J.
    Lubenova, B.
    Kanovsky, P.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S200 - S200
  • [48] Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis
    Liu, Shilian
    Bai, Shumei
    Qin, Zhaoyu
    Yang, Yinrong
    Cui, Yazhou
    Qin, Yanjiang
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (8A) : 1586 - 1603
  • [49] Reduction of angiotensin II in the cerebrospinal fluid of patients with multiple sclerosis
    Kowajiri, M.
    Mogi, M.
    Osoegawa, M.
    Matsuoka, T.
    Tsukuda, K.
    Kohara, K.
    Horiuchi, M.
    Miki, T.
    Kira, J. I.
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (04) : 557 - 560
  • [50] Characterisation of cell populations in cerebrospinal fluid of patients with multiple sclerosis
    Kuenz, B.
    Lutterotti, A.
    Ehling, R.
    Gneiss, C.
    Khalil, M.
    Deisenhammer, F.
    Berger, T.
    Reindl, M.
    MULTIPLE SCLEROSIS, 2006, 12 : S64 - S64
12345